Incyte market cap
WebApr 12, 2024 · The firm has a market cap of $16.62 billion, a P/E ratio of 49.03, a PEG ratio of 3.28 and a beta of 0.73. The firm has a 50-day moving average price of $76.11 and a two-hundred day moving average price of $76.92. Incyte has a 52-week low of $65.07 and a 52-week high of $86.29. Gilead Sciences: Now is Not the Time to Get Sticker Shock WebIncyte market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded …
Incyte market cap
Did you know?
WebDec 21, 2024 · Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include … WebApr 15, 2024 · Incyte Co. has a twelve month low of $65.07 and a twelve month high of $86.29. The stock has a market cap of $16.66 billion, a price-to-earnings ratio of 49.56, a …
WebApr 6, 2024 · INCY stock opened at $73.78 on Thursday. The company's 50 day moving average is $76.94 and its 200 day moving average is $76.65. The stock has a market cap of $16.45 billion, a price-to-earnings ratio of 48.54, a price-to-earnings-growth ratio of 3.14 and a … WebMar 7, 2024 · Incyte has a collaboration agreement with Eli Lilly for Olumiant. The drug is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to LLY. It is approved for several types of...
WebArtiva Biotherapeutics, Inc. (ARTV) Stock Price, Quote & News - Stock Analysis Artiva Biotherapeutics, Inc. ( ARTV) Artiva Biotherapeutics was planning to go public, but the IPO has been withdrawn. Stock Price: Pending IPO price not available yet Overview Statistics Profile Chart not available yet Data will show when the stock starts trading. Web1 day ago · Incyte has a market cap or net worth of $17.61 billion as of February 20, 2024. Incyte's market cap has increased by 18.09% in one year. Market Cap 17.61B Enterprise …
WebApr 15, 2024 · Incyte Co. has a twelve month low of $65.07 and a twelve month high of $86.29. The stock has a market cap of $16.66 billion, a price-to-earnings ratio of 49.56, a P/E/G ratio of 3.22 and a beta of 0.73. The company has a quick ratio of 3.50, a current ratio of 3.54 and a debt-to-equity ratio of 0.01.
WebApr 12, 2024 · The company has a market cap of $16.54 billion, a P/E ratio of 48.80, a price-to-earnings-growth ratio of 3.28 and a beta of 0.73. Incyte ( NASDAQ:INCY – Get Rating ) last released its quarterly ... black and copper kettle the rangeWebMar 11, 2024 · Incyte's ruxolitinib, a type of non-steroidal anti-inflammatory medication called a JAK inhibitor, already makes up a major chunk of earnings, representing $2.22 … black and copper kitchenWebApr 10, 2024 · Market Cap $16.45B Shares Outstanding 222.97M Public Float 220.79M Beta 0.68 Rev. per Employee $1.461M P/E Ratio 49.62 EPS $1.52 Yield N/A Dividend N/A Ex-Dividend Date N/A Short Interest 6.53M... dave and busters cedar rapidsWebApr 15, 2024 · The firm has a market cap of $16.61 billion, a PE ratio of 49.01, a price-to-earnings-growth ratio of 3.21 and a beta of 0.73. Incyte ( NASDAQ:INCY – Get Rating ) last released its quarterly ... dave and busters cedar rapids iowaWebMar 23, 2024 · Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate … black and copper dining tableWebMarket Cap Historical daily share price chart and data for Incyte since 1993 adjusted for splits. The latest closing stock price for Incyte as of April 06, 2024 is 75.51. The all-time high Incyte stock closing price was 152.66 on March 15, 2024. The Incyte 52-week high stock price is 86.29, which is 14.3% above the current share price. black and copper countertopsWebApr 5, 2024 · In the past 30 days, estimates for Novo Nordisk’s 2024 earnings per share have risen from $4.20 to $4.43 and estimates for 2024 have gone up by 29 cents to $5.19. Ligand’s earnings per share... dave and busters central expressway